NCT05468346View on ClinicalTrials.gov

Study on the Body Mass Balance and Biotransformation of [14C]-HEC585

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

August 14, 2022

Study Completion Date

August 29, 2022

Conditions
Healthy Volunteer
Interventions
DRUG

[14C]-HEC585

Single Dose = Solution containing 200 mg/100 µCi \[14C\]-HEC585

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY